Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 7
1963 4
1964 7
1965 8
1966 4
1967 6
1968 6
1969 14
1970 15
1971 10
1972 8
1973 8
1974 3
1975 2
1976 2
1977 7
1978 3
1979 5
1980 5
1981 1
1982 6
1983 8
1984 9
1985 7
1986 4
1987 6
1988 7
1989 5
1990 5
1991 6
1992 1
1993 9
1994 14
1995 9
1996 10
1997 15
1998 13
1999 23
2000 12
2001 9
2002 16
2003 22
2004 17
2005 27
2006 14
2007 26
2008 17
2009 24
2010 19
2011 15
2012 16
2013 18
2014 17
2015 19
2016 35
2017 19
2018 32
2019 42
2020 45
2021 59
2022 45
2023 54
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

852 results

Results by year

Filters applied: . Clear all
Page 1
Dydrogesterone use in early pregnancy.
Mirza FG, Patki A, Pexman-Fieth C. Mirza FG, et al. Gynecol Endocrinol. 2016;32(2):97-106. doi: 10.3109/09513590.2015.1121982. Epub 2016 Jan 22. Gynecol Endocrinol. 2016. PMID: 26800266 Review.
This review describes the efficacy of dydrogesterone for the treatment of threatened and recurrent miscarriage, and infertility due to luteal phase insufficiency. Data from clinical trials evaluating dydrogesterone in assisted reproductive technology are also discus …
This review describes the efficacy of dydrogesterone for the treatment of threatened and recurrent miscarriage, and infertility due t …
Dydrogesterone and the immunology of pregnancy.
Raghupathy R, Szekeres-Bartho J. Raghupathy R, et al. Horm Mol Biol Clin Investig. 2016 Aug 1;27(2):63-71. doi: 10.1515/hmbci-2015-0062. Horm Mol Biol Clin Investig. 2016. PMID: 26812877 Review.
Progestogens have been shown to have very interesting effects on cytokine production and decidual natural killer (NK) cell activity. The orally-administered progestogen, dydrogesterone, has the ability to modulate cytokine production patterns in a manner that could be cond …
Progestogens have been shown to have very interesting effects on cytokine production and decidual natural killer (NK) cell activity. The ora …
Dydrogesterone and pre-term birth.
Hudic I, Schindler AE, Szekeres-Bartho J, Stray-Pedersen B. Hudic I, et al. Horm Mol Biol Clin Investig. 2016 Sep 1;27(3):81-3. doi: 10.1515/hmbci-2015-0064. Horm Mol Biol Clin Investig. 2016. PMID: 26812800 Review.
Over time, various attempts have been made to clarify the question, whether progestogens can contribute positively to either prevention or treatment of pre-term labor and birth. Dydrogesterone treatment of women at risk of pre-term delivery results in increased PIBF produc …
Over time, various attempts have been made to clarify the question, whether progestogens can contribute positively to either prevention or t …
Dydrogesterone indications beyond menopausal hormone therapy: an evidence review and woman's journey.
Stute P. Stute P. Gynecol Endocrinol. 2021 Aug;37(8):683-688. doi: 10.1080/09513590.2021.1908252. Epub 2021 Apr 19. Gynecol Endocrinol. 2021. PMID: 33866898 Review.
Dydrogesterone is an orally active synthetic progestogen, with a molecular structure similar to that of natural progesterone. ...In this narrative review, evidence is examined for use of dydrogesterone across a range of disorders affecting menses and pregnancy. ...
Dydrogesterone is an orally active synthetic progestogen, with a molecular structure similar to that of natural progesterone. ...In t
A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
Tournaye H, Sukhikh GT, Kahler E, Griesinger G. Tournaye H, et al. Hum Reprod. 2017 May 1;32(5):1019-1027. doi: 10.1093/humrep/dex023. Hum Reprod. 2017. PMID: 28333318 Free PMC article. Clinical Trial.
MAIN RESULTS AND THE ROLE OF CHANCE: In the full analysis set (FAS), 497 and 477 subjects in the oral dydrogesterone and MVP groups, respectively, had an embryo transfer. Non-inferiority of oral dydrogesterone was demonstrated, with pregnancy rates at 12 weeks of ge …
MAIN RESULTS AND THE ROLE OF CHANCE: In the full analysis set (FAS), 497 and 477 subjects in the oral dydrogesterone and MVP groups, …
Role of Dydrogesterone for Luteal Phase Support in Assisted Reproduction.
Patki A. Patki A. Reprod Sci. 2024 Jan;31(1):17-29. doi: 10.1007/s43032-023-01302-z. Epub 2023 Jul 24. Reprod Sci. 2024. PMID: 37488405 Review.
Ovarian hyperstimulation during IVF cycles causes luteal phase deficiency, a condition of insufficient progesterone. Intramuscular or vaginal progesterone and dydrogesterone are commonly used for luteal phase support in FET. Oral dydrogesterone has a higher bioavail …
Ovarian hyperstimulation during IVF cycles causes luteal phase deficiency, a condition of insufficient progesterone. Intramuscular or vagina …
Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction.
Griesinger G, Tournaye H, Macklon N, Petraglia F, Arck P, Blockeel C, van Amsterdam P, Pexman-Fieth C, Fauser BC. Griesinger G, et al. Reprod Biomed Online. 2019 Feb;38(2):249-259. doi: 10.1016/j.rbmo.2018.11.017. Epub 2018 Dec 15. Reprod Biomed Online. 2019. PMID: 30595525 Review.
Various micronized progesterone formulations with differing pharmacological profiles have been investigated for several purposes. Dydrogesterone, a stereoisomer of progesterone, is available in an oral form with high oral bioavailability; it has been used to treat a variet …
Various micronized progesterone formulations with differing pharmacological profiles have been investigated for several purposes. Dydroge
Research progress of dydrogesterone in the treatment of endometriosis.
Tang W, Zhu X, Bian L, Zhang B. Tang W, et al. Eur J Obstet Gynecol Reprod Biol. 2024 May;296:120-125. doi: 10.1016/j.ejogrb.2024.02.034. Epub 2024 Feb 20. Eur J Obstet Gynecol Reprod Biol. 2024. PMID: 38430648 Free article. Review.
Clinically, dydrogesterone treatment of endometriosis can relieve patients' symptoms, promote fertility, be used in combination, and is safe. This article will review the mechanism and clinical application of dydrogesterone in the treatment of endometriosis....
Clinically, dydrogesterone treatment of endometriosis can relieve patients' symptoms, promote fertility, be used in combination, and …
The Role of Dydrogesterone in the Management of Luteal Phase Defect: A Comprehensive Review.
Muneeba S Jr, Acharya N, Mohammad S. Muneeba S Jr, et al. Cureus. 2023 Nov 3;15(11):e48194. doi: 10.7759/cureus.48194. eCollection 2023 Nov. Cureus. 2023. PMID: 38050524 Free PMC article. Review.
Dydrogesterone, a synthetic progestogen, closely mirrors natural progesterone's actions, effectively supplementing the luteal phase and enhancing endometrial receptivity. ...Furthermore, dydrogesterone's inclusion in international guidelines solidifies its importanc
Dydrogesterone, a synthetic progestogen, closely mirrors natural progesterone's actions, effectively supplementing the luteal phase a
A critical appraisal of safety data on dydrogesterone for the support of early pregnancy: a scoping review and meta-analysis.
Katalinic A, Shulman LP, Strauss JF, Garcia-Velasco JA, van den Anker JN. Katalinic A, et al. Reprod Biomed Online. 2022 Aug;45(2):365-373. doi: 10.1016/j.rbmo.2022.03.032. Epub 2022 Apr 10. Reprod Biomed Online. 2022. PMID: 35644880 Free article. Review.
The literature was reviewed but it was not possible to identify any evidence of a plausible mechanism for potential causality between dydrogesterone and fetal abnormalities. To investigate whether any evidence existed, a preliminary meta-analysis was undertaken of clinical …
The literature was reviewed but it was not possible to identify any evidence of a plausible mechanism for potential causality between dyd
852 results